Skip to content

Treatment of Common Cold with Unani medicine Laooq-e-Shamoon

Clinical Validation of Unani Pharmacopoeial Formulation Laooq-e-Shamoon in Nazla Haar (Common Cold)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022882
Enrollment
240
Registered
2020-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Laooq-e-Shamoon: 5 gms orally twice daily with water after meals for one week Control Intervention1: Nil: Nil

Sponsors

Central Council for Research in Unani Medicine CCRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 18-65 2. Patients of Nazla Haar presenting the following sign and symptoms: a. Redness of Face b. Redness of Eyes c. Nasal irritation/ Nasal Itching d. Discharge of yellowish secretion of thin consistency

Exclusion criteria

Exclusion criteria: 1. Known cases of Acute or Chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis. 2. Fever > 100oF. 3. History of hepatic, renal disorders, Diabetes Mellitus, Hypertension, or any other ailment needing long term therapy. 4. Known cases of any other acute illness. 5. Known cases of long standing chronic illnesses. 6. Pregnant and lactating women. 7. History of Addiction (smoking, alcohol).

Design outcomes

Primary

MeasureTime frame
Improvement in sign and symptoms of Nazla Haar (Common Cold)Timepoint: 7days

Secondary

MeasureTime frame
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026